林達控股(01041.HK):證券經紀業務暫停 繼續停牌
格隆匯 2 月 2日丨林達控股(01041.HK)公吿,公司向百慕達最高法院提交了清盤呈請,於2020年12月18日上午九時三十分(百慕達時間)在百慕達法院舉行的百慕達呈請聆訊,已延期至2021年3月19日上午九時三十分(百慕達時間)進行。
董事認為,美國與中國間的持續不穩定關係、香港的經濟和政治動盪以及COVID-19衰退對集團的業務產生了重大影響。集團已受到回收應收貸款及已付按金的問題影響。由於營運資金不足,證券經紀和提供證券保證金融資及資產管理的業務已暫停,貸款融資服務以及電子產品貿易和製造的業務受到不利影響。
繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.